Stryker Revenue 2006-2018 | SYK

Stryker annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Stryker revenue for the quarter ending June 30, 2018 was $3.322B, a 10.29% increase year-over-year.
  • Stryker revenue for the twelve months ending June 30, 2018 was $13.040B, a 9.06% increase year-over-year.
  • Stryker annual revenue for 2017 was $12.444B, a 9.88% increase from 2016.
  • Stryker annual revenue for 2016 was $11.325B, a 13.86% increase from 2015.
  • Stryker annual revenue for 2015 was $9.946B, a 2.8% increase from 2014.
Stryker Annual Revenue
(Millions of US $)
2017 $12,444
2016 $11,325
2015 $9,946
2014 $9,675
2013 $9,021
2012 $8,657
2011 $8,307
2010 $7,320
2009 $6,723
2008 $6,718
2007 $6,001
2006 $5,147
2005 $4,609
Stryker Quarterly Revenue
(Millions of US $)
Q2 2018 $3,322
Q1 2018 $3,241
Q4 2017 $3,471
Q3 2017 $3,006
Q2 2017 $3,012
Q1 2017 $2,955
Q4 2016 $3,157
Q3 2016 $2,833
Q2 2016 $2,840
Q1 2016 $2,495
Q4 2015 $2,715
Q3 2015 $2,420
Q2 2015 $2,432
Q1 2015 $2,379
Q4 2014 $2,618
Q3 2014 $2,389
Q2 2014 $2,363
Q1 2014 $2,305
Q4 2013 $2,468
Q3 2013 $2,151
Q2 2013 $2,212
Q1 2013 $2,190
Q4 2012 $2,338
Q3 2012 $2,052
Q2 2012 $2,106
Q1 2012 $2,161
Q4 2011 $2,215
Q3 2011 $2,031
Q2 2011 $2,046
Q1 2011 $2,015
Q4 2010 $1,995
Q3 2010 $1,768
Q2 2010 $1,758
Q1 2010 $1,799
Q4 2009 $1,834
Q3 2009 $1,653
Q2 2009 $1,634
Q1 2009 $1,601
Q4 2008 $1,718
Q3 2008 $1,653
Q2 2008 $1,713
Q1 2008 $1,634
Q4 2007 $1,658
Q3 2007 $1,453
Q2 2007 $1,464
Q1 2007 $1,426
Q4 2006 $1,333
Q3 2006 $1,231
Q2 2006 $1,262
Q1 2006 $1,321
Q4 2005 $1,016
Q3 2005 $1,172
Q2 2005 $1,219
Q1 2005 $1,203
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $63.182B $12.444B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.867B 19.45
Abbott Laboratories (ABT) United States $118.574B 24.05
Boston Scientific (BSX) United States $50.532B 26.29
Baxter (BAX) United States $37.110B 25.26
Zimmer Biomet Holdings (ZBH) United States $25.314B 16.26
ResMed (RMD) United States $14.694B 29.17
Smith & Nephew SNATS (SNN) United Kingdom $14.608B 0.00
Canopy Growth (CGC) Canada $10.780B 0.00
Perrigo (PRGO) Ireland $9.837B 13.96
Bio-Rad Laboratories (BIO) United States $8.382B 53.82
Hill-Rom Holdings (HRC) United States $5.797B 19.66
Haemonetics (HAE) United States $5.495B 50.15
ICU Medical (ICUI) United States $5.418B 36.71
Insulet (PODD) United States $5.203B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.301B 0.00
Hutchison China MediTech (HCM) China $4.012B 0.00
Agios Pharmaceuticals (AGIO) United States $3.879B 0.00
Neogen (NEOG) United States $3.281B 49.69
NuVasive (NUVA) United States $3.191B 30.27
National Vision Holdings (EYE) United States $3.137B 69.28
Quidel (QDEL) United States $2.525B 51.73
NxStage Medical (NXTM) United States $1.815B 0.00
Phibro Animal Health (PAHC) United States $1.784B 25.40
Cardiovascular Systems (CSII) United States $1.263B 727.80
AtriCure (ATRC) United States $1.071B 0.00
VAREX IMAGING (VREX) United States $0.985B 16.09
Owens & Minor (OMI) United States $0.934B 9.99
OraSure Technologies (OSUR) United States $0.904B 59.08
Cerus (CERS) United States $0.887B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.874B 25.81
PetIQ (PETQ) United States $0.862B 28.18
Surmodics (SRDX) United States $0.842B 101.77
MacroGenics (MGNX) United States $0.792B 0.00
Omeros (OMER) United States $0.770B 0.00
Insys Therapeutics (INSY) United States $0.662B 0.00
Meridian Bioscience (VIVO) United States $0.660B 22.57
LeMaitre Vascular (LMAT) United States $0.542B 26.97
Lantheus Holdings (LNTH) United States $0.517B 16.07
NanoString Technologies (NSTG) United States $0.452B 0.00
TG Therapeutics (TGTX) United States $0.445B 0.00
Quanterix (QTRX) United States $0.398B 0.00
Evolus (EOLS) United States $0.354B 0.00
Utah Medical Products (UTMD) United States $0.325B 20.90
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.323B 0.00
Cytosorbents (CTSO) United States $0.321B 0.00
Surface Oncology (SURF) United States $0.220B 0.00
Rockwell Medical (RMTI) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.204B 0.00
Chimerix (CMRX) United States $0.173B 0.00
Fonar (FONR) United States $0.149B 7.32
Conatus Pharmaceuticals (CNAT) United States $0.144B 0.00
Chembio Diagnostics (CEMI) United States $0.137B 0.00
United-Guardian (UG) United States $0.080B 17.61
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.31
Imprimis Pharmaceuticals (IMMY) United States $0.070B 0.00
Neurotrope (NTRP) United States $0.057B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Akers Biosciences Inc (AKER) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00